|1.||Hu, Guo-fu: 9 articles (05/2014 - 06/2002)|
|2.||Lip, Gregory Y H: 9 articles (08/2013 - 12/2007)|
|3.||Hu, Guo-Fu: 8 articles (05/2014 - 01/2005)|
|4.||Marioni, Gino: 6 articles (09/2015 - 10/2010)|
|5.||Blandamura, Stella: 6 articles (09/2015 - 10/2010)|
|6.||Giacomelli, Luciano: 6 articles (09/2015 - 10/2010)|
|7.||Staffieri, Alberto: 6 articles (09/2015 - 10/2010)|
|8.||Xu, Zhengping: 6 articles (05/2014 - 04/2005)|
|9.||Chandran, Bala: 6 articles (05/2014 - 04/2009)|
|10.||Yoshioka, Norie: 6 articles (05/2014 - 09/2006)|
07/01/2003 - "The murine monoclonal antibody 26-2F neutralizes the angiogenic and ribonucleolytic activities of human angiogenin (ANG) and is highly effective in preventing the establishment and metastatic dissemination of human tumors in athymic mice. "
09/01/1997 - "On the basis of our results, ANI-E peptide may be effective for the treatment of various human tumors that secrete angiogenin. "
03/01/2009 - "To study the inhibition of angiogenin (ANG) expression in human lung squamous cancer cell strain-A549 through adeno-associated virus (AAV)-mediated RNA-interference, and therefore to observe its effect on the growth of cancer cells and tumor formation. "
11/27/2007 - "These findings provide new clues for further studies on the mechanisms of angiogenin-induced angiogenesis or cancer cell growth."
11/01/2015 - "Overexpression of angiogenin in tumor cells facilitated angiogenic activation in both in vitro and in vivo models via inhibition of miR-542-3p. "
09/01/2013 - "The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study."
07/01/2005 - "The results of this study demonstrated that the plasma levels of angiogenin were significantly higher in patients who had bladder carcinoma compared with healthy control participants and in patients with superficial bladder carcinoma who had recurrent disease compared with patients who were without recurrence. "
11/01/2015 - "In addition, the level of angiogenin in primary breast carcinomas correlated with clinical progression. "
01/01/2013 - "Angiogenin expression (in carcinoma or endothelial cells) was not associated with prognosis. "
12/01/2011 - "Neither angiogenin (in the carcinoma cells or endothelial cells) nor EGFR expression were associated with the prognosis in our patients after primary surgery followed by RT for laryngeal SCC. "
05/01/2008 - "Angiogenin modified MSCs enhanced the tolerance of engrafted MSCs to hypoxia injury in vitro and improved their viability in infracted hearts, thus helping preserve the LV contractile function and attenuate LV remodeling through vasculogenesis."
12/01/2011 - "The aim of the present study was to ascertain the prognostic importance of hypoxia-inducible factors (CD105, angiogenin) and EGFR in a series of patients who underwent primary surgery followed by RT for laryngeal SCC. "
04/01/2013 - "Angiogenin expression in human kidneys and Wilms' tumours: relationship with hypoxia and angiogenic factors."
02/01/2011 - "The increase in angiogenin concentration in the serum in patients with SSc may confirm endothelial damage caused by hypoxia and reduced vascular perfusion due to the course of SSc without contributing to compensatory revascularization."
09/01/2009 - "We have recently identified mutations in the hypoxia-responsive gene, angiogenin (ANG), in ALS patients, and have shown that ANG is constitutively expressed in motoneurons. "
03/01/2003 - "In conclusion, serum angiogenin may be a valuable marker of differential diagnosis of GTDs and its serial measurements are suggestive of remission and effective therapeutic intervention or disease progression."
08/07/2012 - "Further study should be needed to evaluate the possibility of serum angiogenin as a biomarker of AD and as a predictor of disease progression."
11/28/2006 - "Further investigation will be required to assess the utility of serum angiogenin as a biomarker for ALS and as a predictor of disease progression."
03/01/2003 - "Serial angiogenin assays were correlated with disease progression and were positively correlated with serum hCGb (r = 0.75, p < 0.01). "
11/01/2015 - "Together, these findings reveal a novel regulatory pathway whereby tumor-derived angiogenin directly activates angiogenesis through inhibition of miR-542-3p, suggesting that angiogenin may represent a promising target for anti-angiogenic therapy and a potential marker for monitoring disease progression. "
|5.||Urinary Bladder Neoplasms (Bladder Cancer)
04/01/2015 - "Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway."
08/01/2001 - "The biological role of angiogenin in carcinogenesis of bladder cancer may be different from those of other angiogenic factors."
08/01/2001 - "The present results show that the expression of angiogenin is lower in superficial bladder cancer tissues than in corresponding normal tissues. "
08/01/2001 - "Angiogenin expression was weak in the bladder cancer cells. "
08/01/2001 - "Angiogenin expression in superficial bladder cancer."
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|3.||Messenger RNA (mRNA)
|5.||Immunoglobulin M (IgM)
|6.||Keratin-20 (Cytokeratin 20)
|7.||Fibroblast Growth Factor 1 (FGF-1)
|10.||Angiogenesis Inducing Agents (Angiogenesis Factor)
|1.||Prostatectomy (Retropubic Prostatectomy)
|2.||Renal Dialysis (Hemodialysis)
|3.||Heterologous Transplantation (Xenotransplantation)
|4.||Drug Therapy (Chemotherapy)